Registered entities
Oxford Drug Design Limited
Reg. No. 04305857United Kingdom
Innovation
5 patent families (3 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 134 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 5 |
Social engagement
Social engagement: 2.6K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
57 investors on record; lead investors include IP Group, o2h ventures, ACF Investors, Meltwind Advisory.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 7% |
| Angel & family office | 1 | 2% |
| Accelerator & incubator | 1 | 2% |
| Bank & private debt | 1 | 2% |
| Other / undisclosed | 50 | 88% |